Primary diffuse large B-cell lymphoma of the tonsil: Is a higher radiotherapy dose required?

Cancer

Volumn 110, Issue 4, 2007, Pages 816-823

  Laskar, Siddhartha ^a   Bahl, Gaurav ^a   Muckaden, Mary Ann ^a   Nair, Reena ^a   Gupta, Sudeep ^a   Bakshi, Ashish ^a   Gujral, Sumeet ^a   Shet, Tanuja ^a   Shrivastava, Shyam Kishore ^a   Dinshaw, Ketayun Ardeshir ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Diffuse large B cell lymphoma; Extranodal; Non Hodgkin; Radiotherapy; Tonsil

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INDIA; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; STATISTICAL ANALYSIS; TONSIL TUMOR; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 34547904266     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22841     Document Type: Article

References (24)

1. Doll DC. Introduction: extranodal lymphomas. Semin Oncol. 1999;26:249-250.
2. Jacobs C, Hoppe RT. Non-Hodgkin's lymphoma of head and neck extranodal sites. Int J Radiat Oncol Biol Phys. 1985;11:357-364.
3. Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg. 1986;112:654-658.
4. Banfi A, Bonadonna G, Carnevali G, et al. Lymphoreticular sarcomas with primary involvement of Waldeyer's ring. Cancer. 1970;26:341-351.
5. Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin's lymphoma of the Waldeyer's ring. Eur J Cancer B Oral Oncol. 1996;32B:19-23.
6. Harabuchi Y, Tsubota H, Ohguro S, et al. Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring. Acta Oncol. 1997;36:413-420.
7. Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunological aspects. Cancer. 1985;56:768-776.
8. Saul SH, Kapadia SB. Primary lymphoma of Waldeyer's ring. Clinicopathological study of 68 cases. Cancer. 1985;56:157-166.
9. Bajetta E, Buzzoni R, Rilke F, et al. Non-Hodgkin's lymphomas of Waldeyer's ring. Tumori. 1983;69:129-136.
10. Glick J, Kim K, Earle J, et al. An ECOG randomized phase III trial of CHOP vs CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL) [Abstract]. Proc Am Soc Clin Oncol. 1995;14:1221.
11. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
12. WHO handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization Offset Publication No. 48; 1979.
13. Hoppe RT, Burke JS, Glatstein E, et al. Non-Hodgkin's lymphoma: involvement of Waldeyer's ring. Cancer. 1978;42:1096-1104.
14. Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck. 2001;23:547-558.
15. Kondo M, Mikata A, Ogawa K, et al. Prognostic factors in stage I and II non-Hodgkin's lymphoma of the Waldeyer's ring. Acta Radiol Oncol. 1985;24:153-158.
16. Hart S, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW. Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000). Clin Oncol (R Coll Radiol). 2004;16:186-192.
17. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Treatment results of tonsillar lymphoma: a 10-year experience. Ann Hematol. 2005;84:223-226.
18. Qin Y, Shi YK, He XH, et al. Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil. Ai Zheng. 2006;25:481-485.
19. Gao Y, Li Y, Yuan Z, et al. Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil. Zhonghua Zhong Liu Za Zhi. 2002;24:483-485.
20. Gao YH, Li YX, Zhao LJ, Yuan ZY, Liu XF, Yu ZH. Treatment of early stage primary tonsil non-Hodgkins lymphoma. Zhonghua Xue Ye Xue Za Zhi. 2003;24:190-192.
21. Nathu RM, Mendenhall NP, Almasri NM, Lynch JW. Non-Hodgkin's lymphoma of the head and neck: a 30-year experience at the University of Florida. Head Neck. 1999;21:247-254.
22. Koom WS, Chung EJ, Yang WI, et al. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys. 2004;59:1127-1137.
23. Isobe K, Uno T, Tamaru JI, et al. Extranodal natural killer/T-cell lymphoma, nasal type. Cancer. 2006;106:609-615.
24. Laskar S, Muckaden MA, Bahl G, et al. Primary non-Hodgkin's lymphoma of the nasopharynx: prognostic factors and outcome of 113 Indian patients. Leuk Lymphoma. 2006;47:2132-2139.